Press Centre

Alcyomics® to Transform Drug Discovery for Osteoarthritis Treatment With Unique In Vitro Bio-Printed 3D Tissue Model.

Newcastle upon Tyne, 26 January, 2023. Alcyomics Limited® announces it is seeking partners to participate in validation tests of its unique in vitro 3D bio-printed Osteoarthritis tissue model.
Read more

Alcyomics cell therapy whitepaper

See how Alcyomics can help with cellular therapies.
Read more

Understanding the downsides to animal testing

Animal testing has been, and largely continues to be, a gold standard to test both the efficacy and safety of new pharmaceuticals and therapeutics.
Read more

July Blog 2022 - Immunotoxicity assessment criteria

Immunotoxicity assessment is a huge consideration when developing a new pharmaceutical intended for use in humans. Are 2D cell based systems enough to truly model immunotoxicity?
Read more

JSIT poster sneak peak

Why not also join our mailing list so we can keep you updated with all our exciting news!
Read more

Skimune Nerve - Peripheral neurotoxicity assay

Alcyomics ® has developed a 3D tissue model based in an inert polyHIPE scaffold that enables the culture of multiple cell lineages together in one system.
Read more
Next »